Clinical Trials on Lateral Canthal Lines (LCL)
Total 939 results
-
Galderma R&DCompletedGlabellar Frown Lines (GL) | Lateral Canthal Lines (LCL)United States, Canada
-
Eirion Therapeutics Inc.Active, not recruitingCrow's Feet | Lateral Canthal Lines, LCLUnited States
-
Eirion Therapeutics Inc.CompletedCrow's Feet | Lateral Canthal Lines, LCLUnited States
-
Medy-ToxCompletedLateral Canthal Lines | Glabellar LinesUnited States, Russian Federation, Germany, Canada, Belgium, United Kingdom
-
Medy-ToxCompletedLateral Canthal Lines | Glabellar LinesUnited States, Germany, Canada
-
Medy-ToxCompletedLateral Canthal Lines | Glabellar LinesUnited States, Germany, Canada, United Kingdom
-
AllerganCompletedLateral Canthal Lines | Crow's Feet LinesKorea, Republic of
-
AllerganCompletedLateral Canthal Lines | Crow's Feet LinesChina
-
Galderma R&DCompletedLateral Canthal Lines | Glabellar LinesUnited States, Puerto Rico
-
Smith & Nephew, Inc.CompletedACL Repair | Posterior Cruciate Ligament (PCL) Repair | Medial Collateral Ligament (MCL) | Lateral Collateral Ligament (LCL) | Posterior Oblique Ligament (POL) | Patellar Realignment and Tendon Repairs | Vastus Medialis Obliquus Advancement | Iliotibial Band Tenodesis | Extra-capsular Repairs | Knee RepairUnited States
-
Medy-ToxCompletedLateral Canthal LinesUnited States, Russian Federation, United Kingdom
-
Galderma R&DCompletedLateral Canthal LinesUnited States, Canada
-
Medy-ToxCompletedLateral Canthal LinesAustralia
-
Revance Therapeutics, Inc.Completed
-
IpsenCompletedLateral Canthal LinesFrance, Germany, United Kingdom
-
Eirion Therapeutics Inc.CompletedLateral Canthal Lines | Crow's FeetUnited States
-
Eirion Therapeutics Inc.CompletedLateral Canthal Lines | Crow's FeetUnited States
-
Croma-Pharma GmbHCompletedLateral Canthal Lines | Perioral RhytidsAustria
-
Anterios Inc.Completed
-
Eirion Therapeutics Inc.Completed
-
Anterios Inc.Completed
-
Anterios Inc.CompletedLateral Canthal Lines | Crow's FeetUnited States
-
AllerganCompletedCrow's Feet Lines | Lateral Canthus RhytidesBelgium, Canada, United States, United Kingdom
-
AllerganCompletedCrow's Feet Lines | Lateral Canthus RhytidesJapan
-
Revance Therapeutics, Inc.CompletedUpper Facial Lines (Glabellar Lines, Forehead Lines, & Lateral Canthal Lines)United States, Canada
-
Revance Therapeutics, Inc.CompletedLateral Canthal LinesUnited States
-
Revance Therapeutics, Inc.CompletedLateral Canthal LinesUnited States
-
Merz Pharmaceuticals GmbHCompletedModerate to Severe Upper Facial Lines (Horizontal Forehead Lines, Glabellar Frown Lines, and Lateral Canthal Lines)United States
-
Merz Pharmaceuticals GmbHCompletedModerate to Severe Upper Facial Lines (Horizontal Forehead Lines, Glabellar Frown Lines, and Lateral Canthal Lines)Germany
-
Revance Therapeutics, Inc.CompletedFacial Wrinkles | Lateral Canthal Lines | Crow's FeetUnited States
-
Revance Therapeutics, Inc.CompletedFacial Wrinkles | Lateral Canthal Lines | Crow's FeetUnited States
-
Revance Therapeutics, Inc.CompletedFacial Wrinkles | Lateral Canthal Lines | Crow's FeetUnited States
-
Revance Therapeutics, Inc.CompletedFacial Wrinkles | Lateral Canthal Lines | Crow's FeetUnited States
-
Revance Therapeutics, Inc.CompletedFacial Wrinkles | Lateral Canthal Lines | Crow's FeetUnited States
-
Revance Therapeutics, Inc.CompletedFacial Wrinkles | Lateral Canthal Lines | Crow's FeetUnited States
-
Galderma R&DCompletedGlabellar Frown Lines | Canthal LinesUnited States
-
Galderma R&DCompleted
-
Merz North America, Inc.TerminatedGlabellar Frown Lines and Canthal Lines and/or Horizontal Forehead Lines in the Upper FaceUnited States
-
Infoscitex CorporationMayo Clinic; U.S. Army Medical Research and Development CommandCompletedEvaluation of a New Prosthetic Socket Liner MaterialUnited States
-
Infoscitex CorporationMayo Clinic; U.S. Army Medical Research and Development CommandCompletedEvaluation of a New Prosthetic Socket Liner Material.United States
-
Gruppo Italiano Malattie EMatologiche dell'AdultoCompletedPatients With CLL Relapsing After an Initial Response (CR, PR ≥ 6 Months) Following no More Than Two Prior Treatment Lines; or | Patients With CLL Refractory (SD, PD or CR/PR < 6 Months) Following no More Than Two Prior Treatment LinesItaly
-
University of Texas Southwestern Medical CenterGus Gear IncRecruitingCentral LineUnited States
-
Milton S. Hershey Medical CenterNational Heart, Lung, and Blood Institute (NHLBI)RecruitingCentral Line Complication | Central Line InfectionUnited States
-
Sohag UniversityCompletedCentral Line ComplicationEgypt
-
University of British ColumbiaCompletedCentral Line ComplicationCanada
-
Brno University HospitalCompleted
-
Institute of Medical Sciences and SUM HospitalCompletedUltrasonography | Central Line ComplicationIndia
-
Mahidol UniversityUnknownCentral Line ComplicationThailand
-
Hackensack Meridian HealthActive, not recruiting
-
Lawson Health Research InstituteUniversity of Western Ontario, CanadaCompletedCentral Line ComplicationCanada